Effect of octreotide on the pathology of hepatic schistosomiasis
In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma...
Saved in:
Published in: | Arzneimittel-Forschung Vol. 48; no. 8; p. 855 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Germany
01-08-1998
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma mansoni infection. The material of this investigation consisted of two groups of albino mice (A, B), subdivided each into normal control, infected control, subgroups treated with octreotide, praziquantel (CAS 55268-74-1), and a combination of octreotide and praziquantel. Groups A and B were sacrificed at the 8th week and the 18th week post infection, respectively. By analysis of the obtained results, octreotide induced a reduction of the portal pressure, the weight of the spleen and the liver, the liver egg load (number of eggs) granuloma size and cellularity, and of the degree of hepatic fibrosis quantified by serum N-terminal peptide of type III procollagen in serum, serum laminin and tissue collagen using a Picrosirius red dye assay. Moreover, the biochemical state of hepatocytes has been improved. The subgroups treated with octreotide in association with praziquantel revealed better results than the subgroups treated with praziquantel alone. These obtained data were analysed in terms of histological extent of liver fibrosis in sections stained with Masson trichrome and sirius red, hepatocytic and sinusoidal changes at an ultrastructural level and by immunohistochemical demarcation of endothelial cells of blood vessels through the determination of factor VIII-related antigen. The promising results detected in this study may encourage to further investigate the positive findings of this drug with the intention of its possible application on a clinical level. |
---|---|
AbstractList | In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was undertaken to investigate the possible use of octreotide as an antifibrotic agent and to study its effect on hepatic vasculature in Schistosoma mansoni infection. The material of this investigation consisted of two groups of albino mice (A, B), subdivided each into normal control, infected control, subgroups treated with octreotide, praziquantel (CAS 55268-74-1), and a combination of octreotide and praziquantel. Groups A and B were sacrificed at the 8th week and the 18th week post infection, respectively. By analysis of the obtained results, octreotide induced a reduction of the portal pressure, the weight of the spleen and the liver, the liver egg load (number of eggs) granuloma size and cellularity, and of the degree of hepatic fibrosis quantified by serum N-terminal peptide of type III procollagen in serum, serum laminin and tissue collagen using a Picrosirius red dye assay. Moreover, the biochemical state of hepatocytes has been improved. The subgroups treated with octreotide in association with praziquantel revealed better results than the subgroups treated with praziquantel alone. These obtained data were analysed in terms of histological extent of liver fibrosis in sections stained with Masson trichrome and sirius red, hepatocytic and sinusoidal changes at an ultrastructural level and by immunohistochemical demarcation of endothelial cells of blood vessels through the determination of factor VIII-related antigen. The promising results detected in this study may encourage to further investigate the positive findings of this drug with the intention of its possible application on a clinical level. |
Author | Yehia, H A Hassan, E A Youssef, M M Hassan, M M Hadi, A A Mackenzie, C D Mansy, S S |
Author_xml | – sequence: 1 givenname: S S surname: Mansy fullname: Mansy, S S organization: Department of Electron Microscopy, Theodor Bilharz Research Institute, Imbaba Guiza, Egypt – sequence: 2 givenname: H A surname: Yehia fullname: Yehia, H A – sequence: 3 givenname: M M surname: Hassan fullname: Hassan, M M – sequence: 4 givenname: E A surname: Hassan fullname: Hassan, E A – sequence: 5 givenname: M M surname: Youssef fullname: Youssef, M M – sequence: 6 givenname: A A surname: Hadi fullname: Hadi, A A – sequence: 7 givenname: C D surname: Mackenzie fullname: Mackenzie, C D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/9748716$$D View this record in MEDLINE/PubMed |
BookMark | eNotj81KAzEURrOo1Lb6CEJeYCC5kzTJTin1Bwrd6LpkknudSGcyTOKib69iVx-HAwe-NVuMecQFWwkhVKOkgVu2LuVLCBDGyCVbOqOskdsVe9wTYag8E8-hzphrisjzyGuPfPK1z-f8efnTPf5iCryEPpWaSx6SL6ncsRvy54L3192wj-f9--61ORxf3nZPh2aCVtdGS43GtcqhhdYG0GiFkxABqTNb1bVaa1SCvKMY0ZKxnYzklI4YlUUNG_bw352-uwHjaZrT4OfL6foEfgCpJUYP |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 9748716 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 36B 3O- 4.4 53G 5RE ABCQX ABJNI ACGFS AEIGU ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF EBS ECM EIF EJD EMB EMOBN F5P H13 L7B MK0 NPM O9- P2P RTC SJN SV3 X7J ZGI |
ID | FETCH-LOGICAL-p235t-515e79349e8238c25e80912d2efb764b3555e40fa9fdde8f78b1df945ded48e52 |
ISSN | 0004-4172 |
IngestDate | Sat Sep 28 07:35:35 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 8 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p235t-515e79349e8238c25e80912d2efb764b3555e40fa9fdde8f78b1df945ded48e52 |
PMID | 9748716 |
ParticipantIDs | pubmed_primary_9748716 |
PublicationCentury | 1900 |
PublicationDate | 1998-08-01 |
PublicationDateYYYYMMDD | 1998-08-01 |
PublicationDate_xml | – month: 08 year: 1998 text: 1998-08-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany |
PublicationTitle | Arzneimittel-Forschung |
PublicationTitleAlternate | Arzneimittelforschung |
PublicationYear | 1998 |
SSID | ssj0020771 |
Score | 1.3115757 |
Snippet | In clinical practice, octreotide (CAS 83150-76-9) has its greatest impact in the management of bleeding varices. The present work is the first one which was... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 855 |
SubjectTerms | Animals Blood Vessels - parasitology Blood Vessels - pathology Collagen - metabolism Drug Synergism Female Liver - blood supply Liver - drug effects Liver - parasitology Liver - pathology Liver Cirrhosis, Experimental - metabolism Liver Cirrhosis, Experimental - parasitology Liver Cirrhosis, Experimental - pathology Liver Function Tests Mice Mice, Inbred Strains Octreotide - pharmacology Praziquantel - pharmacology Schistosomiasis mansoni - parasitology Schistosomiasis mansoni - pathology Schistosomicides - pharmacology |
Title | Effect of octreotide on the pathology of hepatic schistosomiasis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9748716 |
Volume | 48 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pa8IwFA5zY-Bl7JfsNzkMTxa0pia9TZzSi0OYg-0kTfOKwmzF6sH99XttYtsJY9thl1KSUEq-5OV7L3lfCLmXuGS4DnAr6LQCiwnZslyZXmamGHMUehB-ttHuPfOnV_HYZ_3tlfDo9edl_4o0liHWaebsH9DOP4oF-I6Y4xNRx-evcDdyxMgB42C1hHg1U2B2BFIR1anWXMoo4iJTa0X3NpUXSOL5zE9mSZmtdpcfEaQZUCt4twbxEpuuzUqXBbGjRJ8UK-KnbzDVp2-9IkjqIT_XYdZhKfaaF_ZNS1Xk4olt6GFrTpnFWvyLOWWiNGxEyTYKrcdbwmAxz0BAlyZ1236s3BHGNjUVUkGWkxLh3jB3tZucm7sS9Q9WyaFpvuM-ZDRifEyODP-nXQ3cCdmD6JTUR1pAfNOg4yIfLmnQOh0V0uKbM_Kg0aVxSAt0aRxRRJfm6KbVBl26g-45eRn0xz3PMndgWAu77awspJuAJpS5IJBcBbYDAhmerWwIJe8wiXTRAdYMfTfEhUqEHGebCl2cZ6CYAMeukf0ojuCCUAVcddogHSnRcju2K8KOEjxQvgLpuuyS1HTPTBZa6GRiuuzqu4prUi2GxQ05CHEOwS2pJGp9l-HxCZRLQBQ |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+octreotide+on+the+pathology+of+hepatic+schistosomiasis&rft.jtitle=Arzneimittel-Forschung&rft.au=Mansy%2C+S+S&rft.au=Yehia%2C+H+A&rft.au=Hassan%2C+M+M&rft.au=Hassan%2C+E+A&rft.date=1998-08-01&rft.issn=0004-4172&rft.volume=48&rft.issue=8&rft.spage=855&rft_id=info%3Apmid%2F9748716&rft_id=info%3Apmid%2F9748716&rft.externalDocID=9748716 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-4172&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-4172&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-4172&client=summon |